FDA也推荐介入治疗后至少延长一年对病人进行双重抗血小板治疗。

The FDA also recommends prolonged dual antiplatelet therapy for at least a year following the intervention.

youdao

FDA也推荐介入治疗后至少延长一年对病人进行双重抗血小板治疗。

The FDA also recommends prolonged dual antiplatelet therapy for at least a year following the intervention.

youdao